| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |